APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Head Lice Infestation Drug

Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.

Selected research

Market Structure

Global Head Lice Infestation Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17399711031 January 2026199 pages

Choose your research edition.

Industry ResearchHead Lice Infestation Drug Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Head Lice Infestation Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Head Lice Infestation Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Head Lice Infestation Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Head Lice Infestation Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.

Global Head Lice Infestation Drug key players include Perrigo, Bayer, Prestige Brands, Stada Arzneimittel, Alliance Pharma, etc. Global top five manufacturers hold a share about 35%. Europe is the largest market, with a share about 40%, followed by North America, with a share about 35 percent. In terms of product, Shampoo is the largest segment, with a share about 45%. And in terms of application, the largest application is Children, followed by Adult.

This report provides an overview of the global Head Lice Infestation Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Head Lice Infestation Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Head Lice Infestation Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Head Lice Infestation Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Head Lice Infestation Drug Segment by Company

Bayer

Omega Pharma

Thornton and Ross

Prestige Brands

Perrigo

Actavis

Reckitt Benckier

Tyratech

Shionogi

TecLabs

Arborpharma

Major Pharmaceuticals

Logic Products

Tianren

ParaPRO

Head Lice Infestation Drug Segment by Type

Lotion

Creams

Shampoo

Other

Head Lice Infestation Drug Segment by Application

Children

Adult

Head Lice Infestation Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Head Lice Infestation Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Head Lice Infestation Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Head Lice Infestation Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Head Lice Infestation Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Head Lice Infestation Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Head Lice Infestation Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Head Lice Infestation Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Head Lice Infestation Drug Industry Trends Table 2. Head Lice Infestation Drug Industry Drivers Table 3. Head Lice Infestation Drug Industry Opportunities and Challenges Table 4. Head Lice Infestation Drug Industry Restraints Table 5. Global Head Lice Infestation Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Head Lice Infestation Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Head Lice Infestation Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Head Lice Infestation Drug Sales Market Share by Manufacturers Table 9. Global Head Lice Infestation Drug Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Head Lice Infestation Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Head Lice Infestation Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Head Lice Infestation Drug Manufacturers, Product Type & Application Table 13. Global Head Lice Infestation Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Head Lice Infestation Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Lotion Table 17. Major Manufacturers of Creams Table 18. Major Manufacturers of Shampoo Table 19. Major Manufacturers of Other Table 20. Global Head Lice Infestation Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Head Lice Infestation Drug Sales by Type (2021-2026) & (K Units) Table 22. Global Head Lice Infestation Drug Sales by Type (2027-2032) & (K Units) Table 23. Global Head Lice Infestation Drug Sales Market Share by Type (2021-2026) Table 24. Global Head Lice Infestation Drug Sales Market Share by Type (2027-2032) Table 25. Global Head Lice Infestation Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Head Lice Infestation Drug Revenue by Type (2021-2026) & (K Units) Table 27. Global Head Lice Infestation Drug Revenue by Type (2027-2032) & (K Units) Table 28. Global Head Lice Infestation Drug Revenue Market Share by Type (2021-2026) Table 29. Global Head Lice Infestation Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Children Table 31. Major Manufacturers of Adult Table 32. Global Head Lice Infestation Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Head Lice Infestation Drug Sales by Application (2021-2026) & (K Units) Table 34. Global Head Lice Infestation Drug Sales by Application (2027-2032) & (K Units) Table 35. Global Head Lice Infestation Drug Sales Market Share by Application (2021-2026) Table 36. Global Head Lice Infestation Drug Sales Market Share by Application (2027-2032) Table 37. Global Head Lice Infestation Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Head Lice Infestation Drug Revenue by Application (2021-2026) & (K Units) Table 39. Global Head Lice Infestation Drug Revenue by Application (2027-2032) & (K Units) Table 40. Global Head Lice Infestation Drug Revenue Market Share by Application (2021-2026) Table 41. Global Head Lice Infestation Drug Revenue Market Share by Application (2027-2032) Table 42. Global Head Lice Infestation Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Head Lice Infestation Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Head Lice Infestation Drug Sales Market Share by Region (2021-2026) Table 45. Global Head Lice Infestation Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Head Lice Infestation Drug Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Head Lice Infestation Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Head Lice Infestation Drug Sales by Country (2021-2026) & (K Units) Table 49. North America Head Lice Infestation Drug Sales by Country (2027-2032) & (K Units) Table 50. Europe Head Lice Infestation Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Head Lice Infestation Drug Sales by Country (2021-2026) & (K Units) Table 52. Europe Head Lice Infestation Drug Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Head Lice Infestation Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Head Lice Infestation Drug Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Head Lice Infestation Drug Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Head Lice Infestation Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Head Lice Infestation Drug Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Head Lice Infestation Drug Sales by Country (2027-2032) & (K Units) Table 59. Global Head Lice Infestation Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Head Lice Infestation Drug Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Head Lice Infestation Drug Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Head Lice Infestation Drug Revenue Market Share by Region (2021-2026) Table 63. Global Head Lice Infestation Drug Revenue Market Share by Region (2027-2032) Table 64. Bayer Company Information Table 65. Bayer Business Overview Table 66. Bayer Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Bayer Head Lice Infestation Drug Product Portfolio Table 68. Bayer Recent Development Table 69. Omega Pharma Company Information Table 70. Omega Pharma Business Overview Table 71. Omega Pharma Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Omega Pharma Head Lice Infestation Drug Product Portfolio Table 73. Omega Pharma Recent Development Table 74. Thornton and Ross Company Information Table 75. Thornton and Ross Business Overview Table 76. Thornton and Ross Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Thornton and Ross Head Lice Infestation Drug Product Portfolio Table 78. Thornton and Ross Recent Development Table 79. Prestige Brands Company Information Table 80. Prestige Brands Business Overview Table 81. Prestige Brands Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Prestige Brands Head Lice Infestation Drug Product Portfolio Table 83. Prestige Brands Recent Development Table 84. Perrigo Company Information Table 85. Perrigo Business Overview Table 86. Perrigo Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Perrigo Head Lice Infestation Drug Product Portfolio Table 88. Perrigo Recent Development Table 89. Actavis Company Information Table 90. Actavis Business Overview Table 91. Actavis Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Actavis Head Lice Infestation Drug Product Portfolio Table 93. Actavis Recent Development Table 94. Reckitt Benckier Company Information Table 95. Reckitt Benckier Business Overview Table 96. Reckitt Benckier Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Reckitt Benckier Head Lice Infestation Drug Product Portfolio Table 98. Reckitt Benckier Recent Development Table 99. Tyratech Company Information Table 100. Tyratech Business Overview Table 101. Tyratech Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Tyratech Head Lice Infestation Drug Product Portfolio Table 103. Tyratech Recent Development Table 104. Shionogi Company Information Table 105. Shionogi Business Overview Table 106. Shionogi Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Shionogi Head Lice Infestation Drug Product Portfolio Table 108. Shionogi Recent Development Table 109. TecLabs Company Information Table 110. TecLabs Business Overview Table 111. TecLabs Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. TecLabs Head Lice Infestation Drug Product Portfolio Table 113. TecLabs Recent Development Table 114. Arborpharma Company Information Table 115. Arborpharma Business Overview Table 116. Arborpharma Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Arborpharma Head Lice Infestation Drug Product Portfolio Table 118. Arborpharma Recent Development Table 119. Major Pharmaceuticals Company Information Table 120. Major Pharmaceuticals Business Overview Table 121. Major Pharmaceuticals Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Major Pharmaceuticals Head Lice Infestation Drug Product Portfolio Table 123. Major Pharmaceuticals Recent Development Table 124. Logic Products Company Information Table 125. Logic Products Business Overview Table 126. Logic Products Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Logic Products Head Lice Infestation Drug Product Portfolio Table 128. Logic Products Recent Development Table 129. Tianren Company Information Table 130. Tianren Business Overview Table 131. Tianren Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Tianren Head Lice Infestation Drug Product Portfolio Table 133. Tianren Recent Development Table 134. ParaPRO Company Information Table 135. ParaPRO Business Overview Table 136. ParaPRO Head Lice Infestation Drug Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. ParaPRO Head Lice Infestation Drug Product Portfolio Table 138. ParaPRO Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Head Lice Infestation Drug Distributors List Table 142. Head Lice Infestation Drug Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Head Lice Infestation Drug Product Image Figure 2. Global Head Lice Infestation Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Head Lice Infestation Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Head Lice Infestation Drug Sales (2021-2032) & (K Units) Figure 5. Global Head Lice Infestation Drug Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Head Lice Infestation Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Lotion Image Figure 9. Creams Image Figure 10. Shampoo Image Figure 11. Other Image Figure 12. Global Head Lice Infestation Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Head Lice Infestation Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Head Lice Infestation Drug Sales Market Share by Type (2021-2032) Figure 15. Global Head Lice Infestation Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Head Lice Infestation Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Head Lice Infestation Drug Revenue Market Share by Type (2021-2032) Figure 18. Children Image Figure 19. Adult Image Figure 20. Global Head Lice Infestation Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Head Lice Infestation Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Head Lice Infestation Drug Sales Market Share by Application (2021-2032) Figure 23. Global Head Lice Infestation Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Head Lice Infestation Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Head Lice Infestation Drug Revenue Market Share by Application (2021-2032) Figure 26. North America Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Head Lice Infestation Drug Sales Market Share by Country (2021-2032) Figure 28. U.S. Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Head Lice Infestation Drug Sales Market Share by Country (2021-2032) Figure 33. Germany Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Head Lice Infestation Drug Sales Market Share by Country (2021-2032) Figure 40. China Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Head Lice Infestation Drug Sales Market Share by Country (2021-2032) Figure 48. Brazil Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Head Lice Infestation Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Head Lice Infestation Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Head Lice Infestation Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Head Lice Infestation Drug Revenue (2021-2032) & (US$ Million) Figure 59. North America Head Lice Infestation Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Head Lice Infestation Drug Revenue (2021-2032) & (US$ Million) Figure 61. Europe Head Lice Infestation Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Head Lice Infestation Drug Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Head Lice Infestation Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Head Lice Infestation Drug Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Head Lice Infestation Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Head Lice Infestation Drug Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Head Lice Infestation Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Lotion
  • Creams
  • Shampoo
  • Other
Applications
  • Children
  • Adult
Companies covered
  • Bayer
  • Omega Pharma
  • Thornton and Ross
  • Prestige Brands
  • Perrigo
  • Actavis
  • Reckitt Benckier
  • Tyratech
  • Shionogi
  • TecLabs
  • Arborpharma
  • Major Pharmaceuticals
  • Logic Products
  • Tianren
  • ParaPRO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Head Lice Infestation Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Head Lice Infestation Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Head Lice Infestation Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Head Lice Infestation Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Head Lice Infestation Drug Market Dynamics
  1. 2.1 Head Lice Infestation Drug Industry Trends
  2. 2.2 Head Lice Infestation Drug Industry Drivers
  3. 2.3 Head Lice Infestation Drug Industry Opportunities and Challenges
  4. 2.4 Head Lice Infestation Drug Industry Restraints
3 Head Lice Infestation Drug Market by Manufacturers
  1. 3.1 Global Head Lice Infestation Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Head Lice Infestation Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Head Lice Infestation Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Head Lice Infestation Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Head Lice Infestation Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Head Lice Infestation Drug Manufacturers, Product Type & Application
  7. 3.7 Global Head Lice Infestation Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Head Lice Infestation Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Head Lice Infestation Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Head Lice Infestation Drug Tier 1, Tier 2, and Tier 3
4 Head Lice Infestation Drug Market by Type
  1. 4.1 Head Lice Infestation Drug Type Introduction
  2. 4.1.1 Lotion
  3. 4.1.2 Creams
  4. 4.1.3 Shampoo
  5. 4.1.4 Other
  6. 4.2 Global Head Lice Infestation Drug Sales by Type
  7. 4.2.1 Global Head Lice Infestation Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Head Lice Infestation Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Head Lice Infestation Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Head Lice Infestation Drug Revenue by Type
  11. 4.3.1 Global Head Lice Infestation Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Head Lice Infestation Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Head Lice Infestation Drug Revenue Market Share by Type (2021-2032)
5 Head Lice Infestation Drug Market by Application
  1. 5.1 Head Lice Infestation Drug Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Head Lice Infestation Drug Sales by Application
  5. 5.2.1 Global Head Lice Infestation Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Head Lice Infestation Drug Sales by Application (2021-2032)
  7. 5.2.3 Global Head Lice Infestation Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global Head Lice Infestation Drug Revenue by Application
  9. 5.3.1 Global Head Lice Infestation Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Head Lice Infestation Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global Head Lice Infestation Drug Revenue Market Share by Application (2021-2032)
6 Global Head Lice Infestation Drug Sales by Region
  1. 6.1 Global Head Lice Infestation Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Head Lice Infestation Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Head Lice Infestation Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Head Lice Infestation Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Head Lice Infestation Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Head Lice Infestation Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Head Lice Infestation Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Head Lice Infestation Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Head Lice Infestation Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Head Lice Infestation Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Head Lice Infestation Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Head Lice Infestation Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Head Lice Infestation Drug Revenue by Region
  1. 7.1 Global Head Lice Infestation Drug Revenue by Region
  2. 7.1.1 Global Head Lice Infestation Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Head Lice Infestation Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Head Lice Infestation Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Head Lice Infestation Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Head Lice Infestation Drug Revenue (2021-2032)
  8. 7.2.2 North America Head Lice Infestation Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Head Lice Infestation Drug Revenue (2021-2032)
  11. 7.3.2 Europe Head Lice Infestation Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Head Lice Infestation Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Head Lice Infestation Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Head Lice Infestation Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Head Lice Infestation Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bayer Head Lice Infestation Drug Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 Omega Pharma
  8. 8.2.1 Omega Pharma Company Information
  9. 8.2.2 Omega Pharma Business Overview
  10. 8.2.3 Omega Pharma Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Omega Pharma Head Lice Infestation Drug Product Portfolio
  12. 8.2.5 Omega Pharma Recent Developments
  13. 8.3 Thornton and Ross
  14. 8.3.1 Thornton and Ross Company Information
  15. 8.3.2 Thornton and Ross Business Overview
  16. 8.3.3 Thornton and Ross Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thornton and Ross Head Lice Infestation Drug Product Portfolio
  18. 8.3.5 Thornton and Ross Recent Developments
  19. 8.4 Prestige Brands
  20. 8.4.1 Prestige Brands Company Information
  21. 8.4.2 Prestige Brands Business Overview
  22. 8.4.3 Prestige Brands Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Prestige Brands Head Lice Infestation Drug Product Portfolio
  24. 8.4.5 Prestige Brands Recent Developments
  25. 8.5 Perrigo
  26. 8.5.1 Perrigo Company Information
  27. 8.5.2 Perrigo Business Overview
  28. 8.5.3 Perrigo Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Perrigo Head Lice Infestation Drug Product Portfolio
  30. 8.5.5 Perrigo Recent Developments
  31. 8.6 Actavis
  32. 8.6.1 Actavis Company Information
  33. 8.6.2 Actavis Business Overview
  34. 8.6.3 Actavis Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Actavis Head Lice Infestation Drug Product Portfolio
  36. 8.6.5 Actavis Recent Developments
  37. 8.7 Reckitt Benckier
  38. 8.7.1 Reckitt Benckier Company Information
  39. 8.7.2 Reckitt Benckier Business Overview
  40. 8.7.3 Reckitt Benckier Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Reckitt Benckier Head Lice Infestation Drug Product Portfolio
  42. 8.7.5 Reckitt Benckier Recent Developments
  43. 8.8 Tyratech
  44. 8.8.1 Tyratech Company Information
  45. 8.8.2 Tyratech Business Overview
  46. 8.8.3 Tyratech Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Tyratech Head Lice Infestation Drug Product Portfolio
  48. 8.8.5 Tyratech Recent Developments
  49. 8.9 Shionogi
  50. 8.9.1 Shionogi Company Information
  51. 8.9.2 Shionogi Business Overview
  52. 8.9.3 Shionogi Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shionogi Head Lice Infestation Drug Product Portfolio
  54. 8.9.5 Shionogi Recent Developments
  55. 8.10 TecLabs
  56. 8.10.1 TecLabs Company Information
  57. 8.10.2 TecLabs Business Overview
  58. 8.10.3 TecLabs Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 TecLabs Head Lice Infestation Drug Product Portfolio
  60. 8.10.5 TecLabs Recent Developments
  61. 8.11 Arborpharma
  62. 8.11.1 Arborpharma Company Information
  63. 8.11.2 Arborpharma Business Overview
  64. 8.11.3 Arborpharma Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Arborpharma Head Lice Infestation Drug Product Portfolio
  66. 8.11.5 Arborpharma Recent Developments
  67. 8.12 Major Pharmaceuticals
  68. 8.12.1 Major Pharmaceuticals Company Information
  69. 8.12.2 Major Pharmaceuticals Business Overview
  70. 8.12.3 Major Pharmaceuticals Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Major Pharmaceuticals Head Lice Infestation Drug Product Portfolio
  72. 8.12.5 Major Pharmaceuticals Recent Developments
  73. 8.13 Logic Products
  74. 8.13.1 Logic Products Company Information
  75. 8.13.2 Logic Products Business Overview
  76. 8.13.3 Logic Products Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Logic Products Head Lice Infestation Drug Product Portfolio
  78. 8.13.5 Logic Products Recent Developments
  79. 8.14 Tianren
  80. 8.14.1 Tianren Company Information
  81. 8.14.2 Tianren Business Overview
  82. 8.14.3 Tianren Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Tianren Head Lice Infestation Drug Product Portfolio
  84. 8.14.5 Tianren Recent Developments
  85. 8.15 ParaPRO
  86. 8.15.1 ParaPRO Company Information
  87. 8.15.2 ParaPRO Business Overview
  88. 8.15.3 ParaPRO Head Lice Infestation Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ParaPRO Head Lice Infestation Drug Product Portfolio
  90. 8.15.5 ParaPRO Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Head Lice Infestation Drug Value Chain Analysis
  2. 9.1.1 Head Lice Infestation Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Head Lice Infestation Drug Production Mode & Process
  6. 9.2 Head Lice Infestation Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Head Lice Infestation Drug Distributors
  9. 9.2.3 Head Lice Infestation Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst